Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists
<p>Abstract</p> <p>Background</p> <p>DNA methylation and histone acetylation are epigenetic modifications that act as regulators of gene expression. Aberrant epigenetic gene silencing in tumours is a frequent event, yet the factors which dictate which genes are targeted...
Main Authors: | Kim Kyu-Tae, Mossman David, Scott Rodney J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-07-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/10/366 |
Similar Items
-
Advances in CpG Island Methylator Phenotype Colorectal Cancer Therapies
by: Xiaofei Zhang, et al.
Published: (2021-02-01) -
Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer
by: Shailesh Mahesh Advani, et al.
Published: (2019-10-01) -
CpG Island Methylator Phenotype and Prognosis of Colorectal Cancer in Northeast China
by: Xia Li, et al.
Published: (2014-01-01) -
The CpG island methylator phenotype in colorectal cancer : studies on risk and prognosis
by: Dahlin, Anna
Published: (2011) -
Global demethylation of rat chondrosarcoma cells after treatment with 5-aza-2'-deoxycytidine results in increased tumorigenicity.
by: Christopher A Hamm, et al.
Published: (2009-12-01)